The second objective was to test whether the MNFY distributed through the dairy value chain and combined with the BCC strategy had an impact on improving hemoglobin (Hb) and reducing anemia among children in dairy farmer households, compared to children from a control group that received the BCC only. The gene discussed is GSTM1; the disease is anemia.